StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3037% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals Total Research and Development (R&D) expenses by Quarter

Total Research and Development (R&D) expenses ($M) ($M)

QuarterlyAnnual

Vertex Pharmaceuticals Total Research and Development (R&D) expenses: $994M in Q2 2026, up 1.6% from a year earlier.

Latest, Q2 2026
994
Period ended Jun 30, 2026
Change on a year earlier
+1.6%
978 in Q2 2025
History
70 quarters
Since Q1 2009
Sources
39
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-04) ↗

Reported in Form 10-Q / 10-K Consolidated Statements of Operations & MD&A.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal Research and Development (R&D) expenses ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026994+1.6%Form 10-Q (filed 2026-08-04) ↗
Q1 2026Mar 31, 2026962-1.8%Form 10-Q (filed 2026-05-05) ↗
Q4 2025Dec 31, 2025974-2.5%Form 10-K (filed 2026-02-13) ↗
Q3 2025Sep 30, 2025978+11.6%Form 10-Q (filed 2025-11-04) ↗
Q2 2025Jun 30, 2025978+1.2%Form 10-Q (filed 2026-08-04) ↗
Q1 2025Mar 31, 2025980+24.2%Form 10-Q (filed 2026-05-05) ↗
Q4 2024Dec 31, 2024999+21.1%Form 10-K (filed 2026-02-13) ↗
Q3 2024Sep 30, 2024876+8.1%Form 10-Q (filed 2025-11-04) ↗
Q2 2024Jun 30, 2024967+23.0%Form 10-Q (filed 2025-08-05) ↗
Q1 2024Mar 31, 2024789+6.3%Form 10-Q (filed 2025-05-06) ↗
Q4 2023Dec 31, 2023825+18.8%Form 10-K (filed 2026-02-13) ↗
Q3 2023Sep 30, 2023810+25.6%Form 10-Q (filed 2024-11-05) ↗
Q2 2023Jun 30, 2023786+30.9%Form 10-Q (filed 2024-08-02) ↗
Q1 2023Mar 31, 2023743+23.5%Form 10-Q (filed 2024-05-07) ↗
Q4 2022Dec 31, 2022694+22.2%Form 10-K (filed 2025-02-13) ↗
Q3 2022Sep 30, 2022645+38.1%Form 10-Q (filed 2023-11-07) ↗

Breakdown

What makes up total Research and Development (R&D) expenses

Cite this data

StockData. (2026). Vertex Pharmaceuticals Total Research and Development (R&D) expenses ($M), quarterly Q1 2009–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/rd-total

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.